Type 2 diabetes and its characteristics during Ramadan in Dhahira region, Oman

Oman Medical Journal

Volumn 22, Issue 3, 2007, Pages 16-23

  Patel, Prakash ^a   Mirakhur, Anoop ^b   El Magd, Karim Mahmoud Abo ^b   El Matty, Abdel Nasser Abo ^b   Al Ghafri, Dalal ^b  

^a Ibri Polyclinic ^*  (Oman)

^b Ibri   (Oman)

Author keywords

Diabetes mellitus; Fasting; Lifestyle changes; Oman; Ramadan; Weight

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; BODY WEIGHT LOSS; CALORIC INTAKE; COLORIMETRY; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; FOLLOW UP; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OMAN; PHYSICAL ACTIVITY; PROBABILITY; RAMADAN FASTING; SMOKING; VERY ELDERLY; WAIST CIRCUMFERENCE;

EID: 85007522481     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 May;27(5):1047-1053.
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998 Sep;21(9):1414-1431.
3. Ministry of Health. Diabetes Mellitus, Management Guidelines for Primary Health Care. Second Edition, November 2003; Oman.
4. Al-Moosa S, Allin S, Jemiai N, Al-Lawati J, Mossialos E. Diabetes and urbanization in the Omani population: an analysis of national survey data. Popul Health Metr 2006;4:5.
5. Al-Riyami AA, Afifi M. Distribution and correlates of total impaired fastiglucose in Oman. East Mediterr Health J 2003 May;9(3):377-389.
6. Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, et al; EPIDIAR study group. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004 Oct;27(10):2306-2311.
7. Azizi F, Siahkolah B. Ramadan fasting and diabetes mellitus. Int J Ramadan Fasting Res 1998;2:8-17.
8. Katibi IA, Akande AA, Bojuwoye BJ, Okesina AB. Blood sugar control among fasting Muslims with type 2 diabetes mellitus in Ilorin. Niger J Med 2001 Jul-Sep;10(3):132-134.
9. Mafauzy M, Mohammed WB, Anum MY, Zulkifli A, Ruhani AH. A study of the fasting diabetic patients during the month of Ramadan. Med J Malaysia 1990 Mar;45(1):14-17.
10. Prevention of Type 2 Diabetes Mellitus by changes in lifestyle, NEJM
11. Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. Lipid Res 1990 Jul;31(7):1149-1172.
12. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990 Jul;336(8708):129-133.
13. First International Congress on Health and Ramadan, Jan 19-22, 1994, Casablanca, Morocco.
14. Rashed AH. The fast of Ramadan. BMJ 1992 Feb;304(6826):521-522.
15. Sulimani RA, Laajam M, Al-Attas O, Famuyiwa FO, Bashi S, Mekki MO. The effect of Ramadan fasting on diabetes control type II diabetic patients. Nutr Res 1991;11:261-264.
16. Laajam MA. Ramadan fasting and non-insulin-dependent diabetes: effect on metabolic control. East Afr Med J 1990 Oct;67(10):732-736.
17. Fakhrzadeh H, Larijani B, Sanjari M, Baradar-Jalili R, Amini MR. Effect of Ramadan fasting on clinical and biochemical parameters in healthy adults. Ann Saudi Med 2003 May-Jul;23(3-4):223-226.
18. Elnasri HA, Ahmed AM. Effect of Ramadan Fasting on Blood Levels of Glucose, Triglyceride and Cholesterol among Type II Diabetes Patients. Sudanese Journal of Public Health 2006;1:203-206.
19. Bouguerra R, Ben Slama C, Belkadhi A, Jabrane H, Beltaifa L, Ben Rayana C, et al. Metabolic control and plasma lipoprotein during Ramadan fasting in non-insulin dependent diabetes. Second International Congress on Health and Ramadan, Dec 1-3, 1997, Istanbul, Turkey, p 33.
20. International Meeting on Diabetes and Ramadan Recommendations: Edition of the Hassan II Foundation for Scientific and Medical Research on Ramadan Casablanca, Morocco, FRSMR, 1995.
21. Al-Arouj M, Bouguerra R, Buse J, Hafez S, Hassanein M, Ibrahim MA, et al. Recommendations for management of diabetes during Ramadan. Diabetes Care 2005 Sep;28(9):2305-2311.
22. Al-Lawati JA, Al Riyami AM, Mohammed AJ, Jousilahti P. Increasing prevalence of diabetes mellitus in Oman. Diabet Med 2002 Nov;19(11):954-957.
23. Southwell A, Eckland D. Managing the burden of type 2 diabetes: an international survey of physicians. Pract Diabetes Int 1997;14:201-206.
24. Al-Lawati JA, Jousilahti PJ. Prevalence and 10-year secular trend of obesity in Oman. Saudi Med J 2004 Mar;25(3):346-351.
25. Al-Riyami AA, Afifi MM. Prevalence and correlates of obesity and centobesity among Omani adults. Saudi Med J 2003 Jun;24(6):641-646.
26. Jönsson B; CODE-2 Advisory Board. Revealing the cost of Type II diabetes in Europe. Diabetologia 2002 Jul;45(7):S5-S12.
27. Khatib FA, Shafagoj YA. Metabolic alterations as a result of Ramadan fasting in non-insulin-dependent diabetes mellitus patients in relation to food intake. Saudi Med J 2004 Dec;25(12):1858-1863.
28. Sari R, Balci MK, Akbas SH, Avci B. The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res 2004 May;30(2):169-177.
29. Yarahmadi Sh, Larijani B, Bastanhagh MH, Pajouhi M, Baradar Jalili R, Zahedi F, et al. Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes. J Coll Physicians Surg Pak 2003 Jun;13(6):329-332.
30. Uysal AR, Erdoğan MF, Sahin G, Kamel N, Erdoğan G. Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramadan. Diabetes Care 1998 Nov;21(11):2033-2034.
31. Qujeq D, Bijani K, Kalavi K, Mohiti J, Aliakbarpour H. Effects of Ramadan fasting on serum low-density and high-density lipoprotein-cholesterol concentrations. Ann Saudi Med 2002 Sep-Nov;22(5-6):297-299.
32. Mafauzy M. Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting. Diabetes Res Clin Pract 2002 Oct;58(1):45-53.
33. Ziaee V, Razaei M, Ahmadinejad Z, Shaikh H, Yousefi R, Yarmohammadi Let al. The changes of metabolic profile and weight during Ramadan fastingSingapore Med J 2006 May;47(5):409-414.
34. Frost G, Pirani S. Meal frequency and nutritional intake during Ramadan: a pilot study. Hum Nutr Appl Nutr 1987 Feb;41(1):47-50.
35. Maislos M, Abu-Rabiah Y, Zuili I, Shaney S. Improved diabetes control after prolonged fasting-the Ramadan model. Pract Diabetes 2001;18:149-151.
36. Qureshi B. Diabetes in Ramadan. J R Soc Med 2002 Oct;95(10):489-490.
37. Abdulhadi N, Al-Shafaee MA, Ostenson CG, Vernby A, Wahlström R. Quality of interaction between primary health-care providers and patients with type 2 diabetes in Muscat, Oman: an observational study. BMC Fam Pract 2006;7:72.